Hot line - First-in-man interventions for valvular heart disease
Session comprising selected EuroPCR 2015 late-breaking trial submissions
Presentations available when logged in:
- Advance in percutaneous tricuspid valve repair: initial outcomes from the first-in-human multicentre study
- 30-day safety and performance results from a first-in-man trial of a low-profile transapical delivery system for transcatheter implantation of an a...
- 30-day VARC-2 and performance data of a new self-expanding transcatheter aortic valve
- 1-year outcome of the COSTA trial: first-in-human implantation of a dry, pre-mounted low-profile TAVI valve
- Septal sinus shortening for the treatment of functional mitral regurgitation: 6-month results